Advancing Precision Medicine for Aggressive Breast Cancer
When you join PMABC, you become part of a dedicated community working to revolutionize treatment for aggressive breast cancer through precision medicine. Your support helps drive groundbreaking research, collaboration, and innovation to improve patient outcomes.
Scroll down to see some of the incredible initiatives we’re leading and discover how you can make a difference!
Research
Women with African ancestry have higher rates of aggressive breast cancers with disadvantaged socio-economic status
Read
Our book is intended for all women of color: educated or uneducated, rich or poor, in Africa or any other part of the world.
Donate
Learn how you can donate and help out!
Breast Cancer and African Ancestry: Lessons Learned at the 10-Year Anniversary of the Ghana-Michigan Research Partnership and International Breast Registry
Abstract Women with African ancestry in western, sub-Saharan Africa and in the United States represent a population subset facing an increased risk of being diagnosed with biologically aggressive phenotypes of breast cancer that are negative for the estrogen receptor, the progesterone receptor, and the HER2/neu marker. These tumors are commonly referred to as triple-negative breast cancer. Disparities…
Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience
Abstract Breast cancers that have negative or extremely low expression of estrogen receptor and progesterone receptor and non-amplification of human epidermal growth factor receptor-2 (HER2)/neu are termed triple-negative breast cancer (TNBC). The majority of TNBC tumors belong to the biologically aggressive basal subtype, and they cannot be managed with targeted endocrine or anti-HER2/neu agents. In…
Global surgical oncology disease burden: addressing disparities via global surgery initiatives: the University of Michigan International Breast Cancer Registry
Abstract Background: Disparities in breast cancer incidence and outcome between African American and white American women are multifactorial in etiology. The increased frequency of triple-negative breast cancers (TNBC) in African American patients suggests the possible contribution of hereditary factors related to African ancestry. Methods: The University of Michigan (UM)-Komfo Anoyke Teaching Hospital (KATH) Breast Cancer Research Collaborative…
MISSION STATEMENT
JIAGGE LAB & PMABC
The Jiagge Lab and PMABC aim to improve patient outcomes by identifying biomarkers for screening and treatment in women with African ancestry with breast cancer and to increase knowledge and access to screening methods in the African American community.
About Us
At the very core of our mission is to improve the standard and quality of care in African breast cancer patients and globally